http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2013151803-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
filingDate 2012-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2013151803-A
titleOfInvention BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS IN THERAPY
abstract 1. The compound of formula (I): or its tautomeric or stereochemically isomeric forms, N-oxides, pharmaceutically acceptable salts or solvates; where Ring E is a 6-membered aromatic carbocyclic or heterocyclic group; G and J are independently selected from C or N; Q is CR or N; R is selected from C1-6alkyl, C1-6alkenyl and - (CH) -cycloalkyl, wherein said C1-6alkyl, C1-6alkenyl and 6-6cycloalkyl, optionally, may be substituted with one or more R groups; R is selected from halogen, —OH and —O — C1-6alkyl; R and R are independently selected from hydrogen, C1-6alkyl, C1-6alkenyl, C1-6alkynyl, —C (═O) NH (C1-6alkyl), - (CH) - (3-12 membered heterocyclyl) and - (CH) -C carbocyclyl, or R and R groups together with the carbon atom to which they are bonded, can combine to form a 3-10 membered saturated carbocyclic or heterocyclic group, wherein said C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, heterocyclic and carbocyclic groups may optionally be substituted with one or more R groups; R and R are independently selected from hydrogen, C1-6alkyl, C1-6 alkenyl, C1-6 alkynyl, -C (= O) NH (C1-6 alkyl), - (CH) - (3-12 membered heterocyclyl), - (CH) -C carbocyclyl, -C (= O) - (3-12 membered heterocyclyl) and -C (= O) -C carbocyclyl, or R and R groups, together with the carbon atom to which they are bonded, can combine to form 3-10 membered of the saturated carbocyclic or heterocyclic group, wherein said C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, heterocyclic and carbocyclic groups may optionally be substituted with one or more R groups; R is selected from hydrogen, C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, -C (= O) NH (C1-6 alkyl) ), - (CH) - (3-12 membered heterocyclyl), - (CH) -C carbocyclyl, -C (= O) - (3-12 membered heterocyclyl) and -C (= O) -C carbocyclyl, where indicated Skilkiln
priorityDate 2011-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467614609

Total number of triples: 29.